4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001628280-26-046653
CEO and President sold 10,000 shares at $16.01 ($160,080)
- CEO and President acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X06/wk-form4_1782947042.xml…